Stay updated on LASER-TBM Clinical Trial

Sign up to get notified when there's something new on the LASER-TBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LASER-TBM Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-13T21:27:48.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study details of the LASER-TBM clinical trial, specifically related to the safety evaluation of increased dose rifampicin (RIF) plus linezolid (LZD), with or without aspirin (ASA), for the treatment of HIV-infected adults with tuberculous meningitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:47.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as HIV-1 seropositivity, age, and specific health conditions. Previously, this section indicated that no information was provided.
    Difference
    16%
    Check dated 2024-05-22T20:58:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:35:20.000Z thumbnail image

Stay in the know with updates to LASER-TBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LASER-TBM Clinical Trial page.